Zdrowie i gospodarka · 15/02/2005

FDA Releases Draft Guidance for Industry on Internal Radioactive Contamination-Development of Decorporation Agents

The Food and Drug Administration (FDA) has released a draft guidance document for the pharmaceutical industry, outlining procedures for developing decorporation agents to treat internal radioactive contamination. The document addresses various aspects of product development, including chemistry, animal studies, and human safety trials.